The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Politics

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by admin May 19, 2025
May 19, 2025
Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS

previous post
Trump’s ‘big, beautiful bill’ passes key House hurdle after GOP rebel mutiny
next post
Biden’s woes converge: Last-minute pardons under fire, calls for prosecution mount following Hur tape release

Related Posts

US military shoots down Houthi drones as Trump’s...

March 17, 2025

Dem senator accuses top Trump official of being...

June 27, 2025

Energy chief envisions US nuclear renaissance: restoring ‘pit’...

March 31, 2025

Vance to visit US troops during high-stakes UK...

August 14, 2025

Mexican president signals possible lawsuit against Google over...

February 14, 2025

Rubio downplays 2028 talk, touts Vance as Trump’s...

July 28, 2025

Trump announces ‘decisive and powerful’ airstrikes against Houthi...

March 16, 2025

US Ambassador to Ukraine Bridget Brink to step...

April 11, 2025

Senate Democrats show shift on Israel as Sanders-backed...

August 13, 2025

Netanyahu apologized for airstrikes during ‘heart-to-heart’ with Qatari...

September 30, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 4

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 5

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved